Retirement Systems of Alabama increased its position in Maximus, Inc. (NYSE:MMS – Free Report) by 48.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 102,030 shares of the health services provider’s stock after buying an additional 33,159 shares during the period. Retirement Systems of Alabama owned about 0.18% of Maximus worth $9,322,000 as of its most recent SEC filing.
A number of other hedge funds have also recently bought and sold shares of the company. Reinhart Partners LLC. raised its holdings in Maximus by 0.8% in the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider’s stock valued at $84,206,000 after acquiring an additional 7,722 shares during the last quarter. Stephens Investment Management Group LLC grew its position in shares of Maximus by 49.0% in the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock valued at $65,873,000 after purchasing an additional 237,097 shares during the period. Norges Bank acquired a new position in Maximus in the second quarter valued at $47,886,000. Boston Partners lifted its position in Maximus by 113.6% during the second quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock worth $46,435,000 after buying an additional 349,529 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in Maximus by 1.6% during the second quarter. Bank of New York Mellon Corp now owns 549,369 shares of the health services provider’s stock worth $38,566,000 after buying an additional 8,434 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.
Analyst Upgrades and Downgrades
MMS has been the subject of several recent analyst reports. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. According to MarketBeat, Maximus has a consensus rating of “Strong Buy”.
Maximus Stock Performance
Maximus stock opened at $94.90 on Thursday. The company has a market cap of $5.18 billion, a price-to-earnings ratio of 17.07 and a beta of 0.56. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $100.00. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.64 and a quick ratio of 1.64. The stock’s 50-day moving average is $89.63 and its 200-day moving average is $85.62.
Maximus (NYSE:MMS – Get Free Report) last posted its earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). The business had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.The firm’s revenue for the quarter was up .2% compared to the same quarter last year. During the same period last year, the company posted $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. Equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be given a dividend of $0.33 per share. This is a positive change from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.32 dividend on an annualized basis and a yield of 1.4%. Maximus’s dividend payout ratio is currently 21.58%.
Insider Transactions at Maximus
In other Maximus news, insider Michelle F. Link sold 4,039 shares of the firm’s stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total value of $350,746.76. Following the transaction, the insider directly owned 19,542 shares of the company’s stock, valued at $1,697,027.28. This trade represents a 17.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.80% of the company’s stock.
About Maximus
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Read More
- Five stocks we like better than Maximus
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
